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Human beings differ widely in their responses to virus
infections. Viruses may induce barely discernible symp-
toms in some patients and severe, life-threatening illness
in others. These differences reflect both the complex,
intimate, and multifaceted nature of virus-host interac-
tions and the variables that can influence these inter-
actions. Viruses elicit a complex temporal sequence of
stringently regulated innate and adaptive immune re-
sponses. These responses are essential for recovery, but
they also contribute to disease symptoms. Optimal in-
nate and adaptive immune responses are therefore bal-
anced at a narrow interface between ineffectual and
overly aggressive. Variables of age, gender, health and
immune status, and genetic background influence the
availability and form of the host metabolites on which
viruses depend; these variables also influence the mag-
nitude and effectiveness of the ensuing host response.
It is well recognized that null mutations of human
genes that are essential for innate or adaptive immune
responses render homozygotes susceptible to diseases
caused by a wide spectrum of viruses. Little is known,
however, about the role that more subtle and ubiquitous
human gene polymorphisms play in virus-disease resis-
tance. Recent highly publicized reports that individuals
who are homozygous for mutant alleles of the CC-che-
mokine receptor 5 (CCR-5) are HIV-1 resistant has stim-
ulated interest in this area of human genetics (Dean et
al. 1996; Samson et al. 1996). CCR-5 is a coreceptor
for macrophage-tropic HIV-1. The mutant allele that
renders homozygotes refractory to HIV-1 infection car-
ries a 32-bp deletion in an extracellular domain and
thereby generates a nonfunctional receptor. This allele
is present in ∼11% of Caucasian populations; ∼1% of
the population is therefore homozygous and highly (but
not absolutely) resistant to HIV-1 infection. Many other
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genetic variations that affect viral receptors are likely to
influence susceptibility to other viruses.
Virus-Resistance Genes—Mice and Humans
More is known about genetic control of resistance to
viruses in mice than in humans. This is because of both
the availability of numerous inbred mouse strains, which
vary in their susceptibility to viruses, and the highly de-
veloped linkage map of the mouse genome.
Mx1 of mice was both the first virus-resistance gene
to be cloned and the first to be used to identify a human
homologue. It encodes a type I interferon–inducible nu-
clear protein that affords specific protection against in-
fluenza viruses. Only three mouse strains, A2G, SL/NiA
and T9, express the antiviral form of protein; other
mouse strains have deletions in theMx1 gene that result
in truncated proteins that are devoid of antiviral activity
(Staeheli et al. 1988). MxA is the human homologue of
Mx1 (Staeheli et al. 1985). Like Mx1, MxA is induced
by type I interferon and inhibits influenza-virus repli-
cation. Virus specificity for MxA is somewhat broader
than virus specificity for Mx1 in that it encompasses
vesicular stomatitis virus and measles virus; and, unlike
Mx1, MxA is a cytoplasmic protein (Pavlovic et al.
1995). Although the mechanisms of virus inhibition by
Mx proteins have not been determined, they appear to
involve GTP binding, GTPase activity, and leucine zip-
pers. Variants of human Mx proteins have not been de-
scribed, but, given the dramatic impact of theMx1 poly-
morphism on influenza-virus resistance in mice,
functional polymorphisms of human Mx proteins could
markedly influence resistance to several important
viruses.
A Lesson about Genes That Code for Virus Receptors
Hv2, another mouse virus-resistance gene, controls re-
sistance to mouse hepatitis virus (MHV), a large-envel-
oped RNA virus that is distantly related to human
enteric and respiratory coronaviruses. As natural path-
ogens of mice, MHV strains may cause either localized
intestinal infections or generalized infections that ema-
nate from the respiratory tract. All MHV strains appear
to use members of the biliary glycoprotein subfamily as
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receptor proteins (Dveksler et al. 1993). The principal
receptors for MHV are several isoforms encoded by the
biliary glycoprotein 1 (Bgp1) gene on the proximal end
of mouse chromosome 7 (Rao et al. 1997).
The SJL inbred mouse strain, unlike almost all other
inbred strains, is highly refractory to MHV infection.
The Bgp1b (Hv2r) allele of SJL mice contains divergent
sequences in the N-terminal virus-binding domain (Kubo
et al. 1994), particularly in the critical residues 38–43
(Rao et al. 1997). The altered Bgp1b isoform remains a
functional virus receptor, but its affinity for MHV is
reduced by one to two orders of magnitude (Ohtsuka
et al. 1996).
Allelic differences of this sort, which reduce but do
not abolish receptor affinity, may be much more com-
mon than the null-receptor phenotype seen in the Ccr5-
D32 homozygotes, especially where the virus receptor
has other essential functions. Quantitative binding stud-
ies, to compare alleles of genes that encode known viral
receptors, may be necessary if alleles are shown to code
for functional receptors. Comparatively small differ-
ences in the affinities of receptors encoded by different
alleles can have dramatic consequences on the course of
virus infections in individuals. In the case of the Bgp1
gene, the 10–100-fold difference in the affinity of the
Bgp1a and Bgpb gene products for MHV translates, after
nine replication cycles, into a 109-fold difference in virus
titers in the major target organs.
Natural Killer–Cell Receptors
Two virus-resistance genes in mice have been mapped
to the natural killer–gene complex (NKC) on distal chro-
mosome 6. The NKC consists of genes that code for
receptors that are expressed almost exclusively by nat-
ural killer (NK) cells. NK cells are bone marrow–derived
large granular lymphocytes, distinct from T and B cells,
that serve as antivirus effectors during the early, prea-
daptive stage of infection. NK cells exert antivirus effects
through direct cytolysis of virus-infected cells and pro-
duction of cytokines.
NK cells lyse virus-infected cells by detecting reduced
expression of major histocompatibility complex (MHC)
class I molecules. Ligated NK-cell receptors specific for
self–MHC class I molecules transduce an inhibitory sig-
nal, but, in the absence of the ligand, these receptors fail
to repress a pathway that culminates in cytokine release
and cytolysis of target cells (fig. 1). In addition to these
inhibitory receptors for self–MHC class I molecules, NK
cells also express receptors that trigger activation of the
cytolytic pathway. Ligands for most activating receptors
are not known at present, but they are believed to be
ubiquitous host molecules rather than of virus origin.
NK-cell receptors that trigger and inhibit activation
are products of two gene complexes that define the
mouse NKC on distal chromosome 6. TheNKR-P1 com-
plex encodes activating receptors (Giorda et al. 1990),
whereas the Ly49 complex encodes primarily, but not
exclusively, inhibitory receptors (Takei et al. 1997).
Products of both complexes are type II transmembrane
proteins of the C-type lectin superfamily. The NKR-P1
complex consists of at least three genes that are differ-
entially expressed between inbred strains of mice
(Giorda and Trucco 1991). The Ly49 gene cluster con-
sists of at least nine genes that encode receptors that
share 49%–92% amino acid–sequence homology. At
least three Ly49 receptors have specificity forMHC class
I molecules and transduce dominant inhibitory signals.
Expression of Ly49 genes in mouse NK cells appears
to incorporate a stochastic component that may result
in random expression of a set of Ly49 genes in individual
NK cells. Each Ly49 receptor is therefore expressed on
a subset of NK cells (Ho¨glund et al. 1997). To prevent
autoimmunity, each NK cell must express at least one
self–MHC class I receptor. In contrast to Ly49, NKR-
P1 genes appear to be universally expressed in NK cells,
in mouse strains that express them (Giorda et al. 1992).
The two virus-resistance genes, Cmv1 and Rmp1, that
have been mapped to the mouse NKC control innate
resistance to mouse cytomegalovirus ([CMV] a herpes
virus) and ectromelia virus (an orthopoxvirus), respec-
tively. Both groups of viruses have complex DNA ge-
nomes that encode host-interactive proteins, many of
which are homologues of host proteins. These include
homologues of cytokines, cytokine receptors, and, in the
case of CMVs, an MHC–class I molecule (Beck and Bar-
rell 1988). This CMV–class I homologue may function
to inhibit NK-cell activation by binding to and activating
an inhibitory class I–specific receptor.
The Cmv1 gene has been mapped (Depatie et al.
1997). It has been proposed that Cmv1, which maps to
the Ly49 gene cluster, encodes alloforms of a Ly49 re-
ceptor in resistant and susceptible strains of mice that
differ in their affinity for the CMV–class I homologue
(Brown et al. 1997). According to this hypothesis, the
allele from resistant strains does not bind the viral li-
gand, so no inhibitory signal is transduced. Alternatively,
Cmv1 or Rmp1 may encode either inhibitory receptors
that are lost in resistant mice or activating receptors that
are not expressed in susceptible mice.
The human NKC on chromosome 12p contains sev-
eral homologues of genes in the murine NKC, but there
are significant differences between the two complexes.
HumanNkr-p1 appears to be a single gene that is ∼46%
homologous with rodent Nkr-p1, which codes for an
inhibitory rather than an activating receptor (Lanier et
al. 1994). Hybridization studies using mouse Ly49
probes have not identified human homologues of Ly49.
Two other genes in the human NKC, Cd94 and Nkg2,
may affect virus resistance. Both are C-type lectins that
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Figure 1 NK-cell recognition of missing self in virus-infected cells. Some NK-cell receptors transduce signals that activate the cytolytic
pathway when they bind specific ligands. Other receptors, specific for self–MHC class I molecules, transduce inhibitory signals in normal cells
that prevent activation of the cytolytic pathway. When expression of class I molecules is inhibited by replicating virus, class I–specific receptors,
in the absence of ligand, fail to repress activation of the cytolytic pathway.
are structurally similar to murine Ly49 and NKR-P1.
Cd94 codes for an invariant molecule that forms het-
erodimers with the products of the three Nkg2 genes.
At least five cDNAs (A–E) have been identified in the
NKG2 family. Depending on which of the NKG2 iso-
forms is expressed in individual NK cells, the resulting
receptor may be activating or inhibitory (Lo´pez-Botet et
al. 1997).
Limits to the Analogy between Mice and Humans
Most HLA–class I inhibitory receptors of human NK
cells are not products of the NKC but are expressed by
a cluster of genes on chromosome 19q13.4 that code for
the killer inhibitory receptors (KIRs). Unlike rodent
NKC-encodedMHC–class I inhibitory receptors, human
p58, p70, and p140 KIRs are type I transmembrane
proteins of the immunoglobulin (Ig) superfamily (Long
et al. 1997). Rodent homologues of KIRs have not been
identified, perhaps because Ig-like molecules adapted to
class I–receptor function after the divergence of rodent
and primate lineages.
Although rodent and human NK cells use different
classes of inhibitory class I–specific receptors, down-
stream signaling events are similar. Both inhibitory ro-
dent Ly49 receptors and human KIRs have cytoplasmic
tails that contain immunoreceptor tyrosine-based inhib-
iting motifs that transduce inhibitory signals by recruit-
ing and activating cytoplasmic protein tyrosine kinases
(Burshtyn et al. 1996). Also, KIRs, like Ly49 in rodents,
do not undergo somatic rearrangement but are highly
complex gene clusters. At least seven genes encode p58
receptors, and p70 receptors are products of a similar
number of genes (Moretta et al. 1997). Activating p58-
related receptors, named “p50,” are also encoded by
genes in this region of chromosome 19. Because of the
presence of both activatory receptors and inhibitory re-
ceptors with HLA–class I or other specificity, the KIR
gene family appears to be a candidate region for virus-
resistance genes in humans.
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These mouse studies suggest that the humanNKC and
KIR gene complexes may contain important virus-resis-
tance genes. The specificity of these genes for particular
viruses may depend on whether Cmv1 and Rmp1 influ-
ence resistance by encoding receptors that bind only vi-
rus homologues of class I molecules. If receptors encoded
by one or both genes bind host ligands, then a wider
spectrum of viruses may be influenced by them.
Conclusion
These examples illustrate how mouse-virus systems
are being used to identify candidate virus-resistance
genes in humans. They provide the probes to detect func-
tional homologues of resistance genes that are shared by
rodent and primate lineages. They delineate novel ge-
netic mechanisms of resistance, such as functional but
less sticky virus receptors. They also highlight specific
genetically complex and polymorphic components of the
innate immune system as sources of variation in human
responses to viruses. Other benefits are likely to emerge
as more mouse virus-resistance genes are identified and
characterized. Clearly, not all details of virus-restriction
pathways are conserved, but even where differences ex-
ist, functional similarities may be enough to guide ge-
netic studies of human resistance to viruses.
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